To Get Help Now
Click Here
 
Today's Date:

Appeals Court Upholds Sulindac Drug Liability

AddThis Social Bookmark Button

The First Circuit Court of Appeals has upheld a products liability verdict that awarded Karen Bartlett of Plaistow, New Hampshire $21.6 million after finding the generic, non-steroid, anti-inflammatory drug Sulindac was unreasonably dangerous.

Bartlett began taking the drug in December 2004 after her physician prescribed it for shoulder pain, and within a few weeks she began to experience problems that led to blindness and severe burning of her mucus membranes and skin.

According to court documents, Bartlett was in the Massachusetts General Hospital burn unit for months and was put into a medically induced coma as she suffered burns to 65 percent of her body. She was forced to undergo over 12 operations on her eyes. First Circuit Judge Michael Boudin wrote “Bartlett cannot eat normally due to esophageal burns, cannot have sexual relations due to vaginal injuries and cannot engage in aerobic activities due to lung injuries,” Boudin wrote. “She cannot read or drive or work. She is seriously disfigured in face and body. ”

Drug maker Mutual Pharmaceutical challenged the verdict, however, the appeals court ruled in favor of the award saying that “Bartlett’s injuries were truly horrific.”

 

 

breakinglawsuitnews.com disclaimer: This article: Appeals Court Upholds Sulindac Drug Liability was posted on Thursday, May 10th, 2012 at 8:33 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Comments are closed.